3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists

Bioorg Med Chem Lett. 2005 Aug 1;15(15):3555-9. doi: 10.1016/j.bmcl.2005.05.061.

Abstract

Novel 3-thio-1,2,4-triazoles have been obtained via a solution-phase parallel synthesis strategy, affording potent non-peptidic human somatostatin receptor subtypes 2 and 5 agonists.

MeSH terms

  • Binding Sites
  • Cyclic AMP / antagonists & inhibitors
  • Cyclic AMP / metabolism
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Receptors, Somatostatin / agonists*
  • Somatostatin / metabolism*
  • Somatostatin / pharmacology
  • Sulfides / chemical synthesis*
  • Sulfides / pharmacology
  • Triazoles / chemical synthesis
  • Triazoles / pharmacology

Substances

  • Receptors, Somatostatin
  • Sulfides
  • Triazoles
  • Somatostatin
  • somatostatin receptor 5
  • somatostatin receptor 2
  • Cyclic AMP